Description
Bdparib 200mg Tablet is a medication containing the active ingredient Olaparib. It belongs to a class of drugs known as PARP inhibitors. These inhibitors work by blocking an enzyme called poly (ADP-ribose) polymerase (PARP), which plays a crucial role in DNA repair within cells. In certain types of cancer, particularly those with specific genetic mutations (like BRCA mutations), cancer cells rely heavily on PARP for survival and repair. By inhibiting PARP, Bdparib can lead to the accumulation of DNA damage in these cancer cells, ultimately causing them to die. Bdparib 200mg Tablet is primarily indicated for the treatment of certain types of advanced ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, especially in patients who have responded to prior platinum-based chemotherapy. It is also used in specific cases of metastatic breast cancer and metastatic pancreatic cancer with BRCA mutations. The typical dosage is 200mg twice daily, taken orally. Common side effects may include nausea, fatigue, headache, loss of appetite, and changes in blood cell counts. It is important to discuss potential side effects and contraindications with your healthcare provider. Store Bdparib 200mg Tablet at room temperature, away from moisture and heat.
